Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JNJ
JNJ
J&J Seeks Court Aid to Protect Its Glucose Monitoring Test
Forbes
Wed, 09/11/13 - 12:56 pm
JNJ
blood glucose monitoring
devices
Lifescan Ultra
Genstrip
Decision Diagnostics
China's Diabetes Market Could Become A Big Focus For Pharma Companies
Seeking Alpha
Wed, 09/11/13 - 11:23 am
China
diabetes
JNJ
Merck
Pfizer
Will a Band-Aid Be Enough for J&J's Latest Recall?
Motley Fool
Wed, 09/11/13 - 09:29 am
JNJ
Motrin
recalls
EU approves biosimilar of J&J and Merck's Remicade, WSJ says
Yahoo/Fly on the Wall
Wed, 09/11/13 - 08:48 am
Europe
biosimilars
JNJ
Merck
Remicade
rheumatoid arthritis
Gorsky And J&J Employees: Phone Calls, Recalls And Distractions
Pharmalot
Tue, 09/10/13 - 10:38 am
Alex Gorsky
JNJ
cell phones
drug reps
Pharma CEOs
J&J Sues Boehringer Ingelheim Over Arbitration Dispute
Bloomberg
Tue, 09/10/13 - 10:21 am
JNJ
Boehringer Ingelheim
Dendreon: Crushed By JNJ/Medivation Or By Own Management?
Seeking Alpha
Mon, 09/9/13 - 05:19 pm
JNJ
Medivation
Dendreon
Provenge
Xtandi
Zytiga
prostate cancer
J&J Watchdog Employee Can Proceed With Retaliation Lawsuit
Pharmalot
Mon, 09/9/13 - 11:16 am
JNJ
whistleblower lawsuits
J&J recalls Infant Motrin due to plastic specks
Yahoo/AP
Sat, 09/7/13 - 12:03 pm
JNJ
recalls
Johnson & Johnson reportedly eyes sale of clinical diagnostics unit
MarketWatch
Sat, 09/7/13 - 12:02 pm
JNJ
Ortho Clinical Diagnostics
M&A
4 Healthcare Stock Stories for Weekend Investment Wellness
Wall Street Cheat Sheet
Mon, 09/9/13 - 09:18 am
TrovaGene
Prosensa
JNJ
Celgene
5 Pharmas Spending the Most on Advertising to Physicians in Print Media
Motley Fool
Thu, 09/5/13 - 06:50 pm
JNJ
Forest Labs
Pfizer
Novartis
Ironwood Pharmaceuticals
Merck Hopes Alzheimer's Drug Fares Better Than Competitors
TheStreet.com
Thu, 09/5/13 - 08:50 am
Merck
Alzheimer's disease
Pfizer
Eli Lilly
JNJ
bapineuzumab
solanezumab
BACE inhibitors
MK-8931
Johnson & Johnson - 2 Strategies To Profit
Seeking Alpha
Wed, 09/4/13 - 01:11 pm
JNJ
Philips, J&J land Defense Dept. contracts worth up to $73M
Mass Device
Tue, 09/3/13 - 11:15 am
devices
defense contracts
government contracts
Philips
JNJ
These 2 Companies Are the Biggest Winners of the FDA's Breakthrough Designation
Motley Fool
Tue, 09/3/13 - 09:33 am
FDA
breakthrough therapies
ibrutinib
Pharmacyclics
JNJ
Novartis
LDK378
serelaxin
daratumumab
Genmab
Facing govt scrutiny and lawsuits, J&J puts warnings on Tylenol caps
Yahoo/AP
Thu, 08/29/13 - 04:53 pm
JNJ
Tylenol
FDA grants priority review to blood cancer treatment from Pharmacyclics
Yahoo/AP
Thu, 08/29/13 - 09:07 am
FDA
Pharmacyclics
Janssen
JNJ
ibrutinib
mantle cell lymphoma
chronic lymphocytic leukemia
Understanding the Massive Market Potential of Monoclonal Antibodies
Motley Fool
Wed, 08/28/13 - 04:53 pm
monoclonal antibodies
Roche
Herceptin
Rituxan
Avastin
GSK
Amgen
Eli Lilly
Bristol-Myers Squibb
Seattle Genetics
Adcetris
Kadcyla
bapineuzumab
Elan
JNJ
Pfizer
necitumumab
AbbVie
Humira
A Closer Look at the Controversial Market Growth of ADHD Treatments
Motley Fool
Wed, 08/28/13 - 04:49 pm
ADHD
Shire
Adderall
Strattera
Eli Lilly
JNJ
Novartis
Concerta
Ritalin
Pages
« first
‹ previous
…
113
114
115
116
117
118
119
120
121
…
next ›
last »